2020, ' Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia ', Stroke . https://doi.org/10.1161/STROKEAHA.120.029474 Du, H, Wilson, D, Ambler, G, Banerjee, G, Shakeshaft, C, Cohen, H, Yousry, T, Al-Shahi Salman, R, Lip, G Y H, Houlden, H, Brown, M M, Muir, K W, Jäger, H R, Werring, D J & Clinical relevance of Microbleeds in Stroke (CROMIS-2) collaborators 2021, ' Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia ', Stroke, vol. 52, no. 1, pp. 91-99 . https://doi.org/10.1161/STROKEAHA.120.029474
Banerjee, G, Chan, E, Ambler, G, Wilson, D, Cipolotti, L, Shakeshaft, C, Cohen, H, Yousry, T, Al-Shahi Salman, R, Lip, G Y H, Muir, K W, Brown, M M, Jäger, H R, Werring, D J & CROMIS-2 Collaborators † 2020, ' Cognitive Impairment Before Atrial Fibrillation-Related Ischemic Events : Neuroimaging and Prognostic Associations ', Journal of the American Heart Association, vol. 9, no. 1, e014537 . https://doi.org/10.1161/JAHA.119.014537 Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2020, ' Cognitive Impairment Before Atrial Fibrillation–Related Ischemic Events: Neuroimaging and Prognostic Associations ', Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease, vol. 9, no. 1 . https://doi.org/10.1161/JAHA.119.014537
Lancet Lancet, Elsevier, 2020, 396 (10262), pp.1574-1584. ⟨10.1016/s0140-6736(20)32163-2⟩ The Lancet The Lancet, 2020, 396 (10262), pp.1574-1584. ⟨10.1016/s0140-6736(20)32163-2⟩ The lancet 396(10262), 1574-1584 (2020). doi:10.1016/S0140-6736(20)32163-2 The lancet : international edition Thomalla, G, Boutitie, F, Ma, H, Koga, M, Ringleb, P, Schwamm, L H, Wu, O, Bendszus, M, Bladin, C F, Campbell, B C V, Cheng, B, Churilov, L, Ebinger, M, Endres, M, Fiebach, J B, Fukuda-Doi, M, Inoue, M, Kleinig, T J, Latour, L L, Lemmens, R, Levi, C R, Leys, D, Miwa, K, Molina, C A, Muir, K W, Nighoghossian, N, Parsons, M W, Pedraza, S, Schellinger, P D, Schwab, S, Simonsen, C Z, Song, S S, Thijs, V, Toni, D, Hsu, C Y, Wahlgren, N, Yamamoto, H, Yassi, N, Yoshimura, S, Warach, S, Hacke, W, Toyoda, K, Donnan, G A, Davis, S M, Gerloff, C & Evaluation of unknown Onset Stroke thrombolysis trials (EOS) investigators 2020, ' Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging : systematic review and meta-analysis of individual patient data ', Lancet, vol. 396, no. 10262, pp. 1574-1584 . https://doi.org/10.1016/S0140-6736(20)32163-2 Lancet (London, England), Vol. 396, no. 10262, p. 1574-1584 (2020) The Lancet, 396(10262), 1574-1584. Elsevier Limited